We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Monogenic Hypercholesterolemia Increases Cardiovascular Disease Risk

By LabMedica International staff writers
Posted on 03 Mar 2020
Monogenic familial hypercholesterolemia (FH) is associated with lifelong elevations in low-density lipoprotein cholesterol (LDL-C) levels and increased risk of atherosclerotic cardiovascular disease (CVD).

However, many individuals' hypercholesterolemia has a polygenic rather than a monogenic cause, and it is unclear if polygenic variants also alter the risk of CVD. More...
Polygenic hypercholesterolemia is estimated to account for approximately 20% to 30% of patients with clinical FH. The risk of CVD for individuals with polygenic hypercholesterolemia likely depends on the reference group.

A team of scientists from University of British Columbia (Vancouver, BC, Canada) conducted a genetic-association case-control cohort study on 48,741 individuals who were recruited by the UK Biobank, using genotyping array and exome sequencing data to identify individuals with monogenic or polygenic hypercholesterolemia. They assessed whether any genetic variant for hypercholesterolemia altered the risk of atherosclerotic CVD, and evaluated how this risk compared with that of nongenetic hypercholesterolemia.

Serum biochemistry assays were conducted on a Beckman Coulter AU5800 analyzer (Beckman Coulter, High Wycombe, UK) or for the glycated hemoglobin (HbA1c) by High Performance Liquid Chromatography using Bio-Rad Variant II Turbo analyzers (Bio-Rad Laboratories, Hercules, CA, USA). Genotyping array and exome sequencing data from the UK Biobank cohort were used to identify individuals with monogenic (LDLR, APOB, and PCSK9) or polygenic hypercholesterolemia (LDL-C polygenic score >95th percentile based on 223 single-nucleotide variants in the entire cohort). The data were analyzed from July 1, 2019, to December 30, 2019.

The team reported a monogenic cause for hypercholesterolemia was found in 277 participants and a polygenic cause in 2,379 participants. Overall, monogenic FH-associated variants were found in the LDLR gene for 257 individuals, in PCSK9 for 13 individuals, and in APOB for seven individuals. They identified a total of 121 unique monogenic FH-associated variants, most of which were in LDLR. Both polygenic and monogenic causes of hypercholesterolemia appeared to be associated with an increased risk of CVD compared with hypercholesterolemia with an undetermined cause. However, monogenic hypercholesterolemia was associated with the greatest risk of CVD.

The authors concluded that monogenic FH and polygenic hypercholesterolemia were associated with an increased CVD risk compared with hypercholesterolemia without an identifiable genetic cause, with monogenic FH associated with the greatest risk. These results suggest that a possible genetic cause of hypercholesterolemia is associated with CVD risk and underscores the importance of genetic profiling to better stratify risk in patients. The study was published on February 12, 2020 in the journal JAMA Cardiology.

Related Links:
University of British Columbia
Beckman Coulter
Bio-Rad Laboratories



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.